These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7410380)

  • 21. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
    Plenge P; Mellerup ET
    Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
    Parent CA; Lagarde M; Venton DL; Le Breton GC
    J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant-binding sites in brain and platelets.
    Langer SZ; Galzin AM; Lee CR; Schoemaker H
    Ciba Found Symp; 1986; 123():3-29. PubMed ID: 3816412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
    Miquel MC; Emerit MB; Bolaños FJ; Schechter LE; Gozlan H; Hamon M
    J Neurochem; 1990 Nov; 55(5):1526-36. PubMed ID: 2213008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p-Chloroamphetamine induces serotonin release through serotonin transporters.
    Rudnick G; Wall SC
    Biochemistry; 1992 Jul; 31(29):6710-8. PubMed ID: 1322169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Solubilization by various detergents, of the muscarinic cholinoreceptor and its complex with quinuclidinyl benzilate].
    Rinken AA; Langel IuL; Iarv IaL
    Biokhimiia; 1987 Feb; 52(2):303-10. PubMed ID: 3567252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
    Phillips OM; Wood KM; Williams DC
    J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complex.
    Abraham KI; Ieni JR; Meyerson LR
    Biochim Biophys Acta; 1987 Jan; 923(1):8-21. PubMed ID: 3542053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".
    Paul SM; Rehavi M; Skolnick P; Ballenger JC; Goodwin FK
    Arch Gen Psychiatry; 1981 Dec; 38(12):1315-7. PubMed ID: 7316676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.
    Marcusson JO; Ross SB
    Psychopharmacology (Berl); 1990; 102(2):145-55. PubMed ID: 2274599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between 3H-imipramine binding, 14C-serotonin uptake, and the surface area of blood platelets.
    Demet EM; Chicz-Demet A; Shaffer E; Ocariz J
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):289-96. PubMed ID: 2163060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing the platelet plasma-membrane 5-hydroxytryptamine transporter.
    Williams DC; Phillips OM
    Biochem Soc Trans; 1991 Feb; 19(1):112-4. PubMed ID: 2037132
    [No Abstract]   [Full Text] [Related]  

  • 35. Solubilization of dopamine D2 receptors with a zwitterionic detergent DCHAPS.
    Soskić V; Petrović J
    Biochem Pharmacol; 1986 Dec; 35(23):4229-36. PubMed ID: 2947577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubilized ketanserin binding sites from pig platelet membranes.
    Wesemann W; Hoffmann D
    Thromb Res; 1985 Sep; 39(6):693-700. PubMed ID: 2934860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-step purification of the serotonin transporter located at the human platelet plasma membrane.
    Launay JM; Geoffroy C; Mutel V; Buckle M; Cesura A; Alouf JE; Da Prada M
    J Biol Chem; 1992 Jun; 267(16):11344-51. PubMed ID: 1534559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The solubilization and morphological change of human platelets in various detergents.
    Shiao YJ; Chen JC; Wang CT
    Biochim Biophys Acta; 1989 Mar; 980(1):56-68. PubMed ID: 2923900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.